Skip to main content

SYSTEMATIC REVIEW article

Front. Adolesc. Med.
Sec. Adolescent and Young Adult Oncology
Volume 2 - 2024 | doi: 10.3389/fradm.2024.1441776

Social Determinants of Health Impact on Cancer Affecting Children, Adolescents, and Young Adults: Systematic Review and Meta-Analysis

Provisionally accepted
Muhannad Sharara Muhannad Sharara 1,2Kellen C. Tjioe Kellen C. Tjioe 2Marisol Miranda Marisol Miranda 2Brenda Santellano Brenda Santellano 2Gagan Agrawal Gagan Agrawal 3,4Andrew Balas Andrew Balas 5Theodore S. Johnson Theodore S. Johnson 6Jorge Cortes Jorge Cortes 2*
  • 1 Augusta University, Augusta, United States
  • 2 Georgia Cancer Center, Augusta University, Augusta, Georgia, United States
  • 3 University of Georgia, Athens, Georgia, United States
  • 4 School of Computing, Franklin College of Arts and Sciences, University of Georgia, Athens, Georgia, United States
  • 5 Institute of Public and Preventive Health, Augusta University, Augusta, Georgia, United States
  • 6 Department of Pediatrics, Medical College of Georgia, Augusta University., Augusta, United States

The final, formatted version of the article will be published soon.

    To analyze the impact of social determinants of health (SDH) on cancer outcomes of children and adolescents and young adults (AYA) treated for cancer.The protocol for this study was registered at PROSPERO (CRD402022346854). A search strategy was implemented across six databases over the last two decades. The focus narrowed to 31 studies conducted in the United States, involving patients between the ages of 15 and 39, assessing survival outcomes based on SDH factors. The Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Analytical Cross-Sectional Studies was employed for risk of bias assessment.The most extensively examined SDH factors were neighborhood socioeconomic status (nSES) and health insurance status. Other variables investigated were location of care (6/31), poverty level (5/31), education level (3/31), marital status (4/31), median income (3/31), travel distance to medical facility (3/31), language isolation (2/31), and unemployment (1/31). The primary outcome evaluated was overall survival (OS) and cancer-specific survival (CSS). Meta-analyses focusing on hematological malignancies revealed statistically significant associations, such as lowest nSES correlating with worse OS (hazard ratio [HR]:1.46, 95%-CI:1.29-1.66) and CSS (HR:1.43, 95%-CI:1.20-1.72), Medicaid/public insurance linked to worse OS (HR: 1.21, 95%-CI:1.16-1.26), and no insurance associated with worse OS (HR:1.35, 95%-CI:1.17-1.55).The study highlights the fragmented and incomplete nature of research on SDH in cancer treatment in this age group. Health insurance coverage and nSES were the most studied, revealing significant impacts on patient survival. Identifying vulnerable Deleted: under 40 years Deleted: patients through such analyses could inform policy decisions and address existing gaps in SDH research more effectively.

    Keywords: social determinants of health, hematological malignancies, pediatric, adolescents, Survival, young adults, Cancer, Hematology

    Received: 31 May 2024; Accepted: 30 Aug 2024.

    Copyright: © 2024 Sharara, Tjioe, Miranda, Santellano, Agrawal, Balas, Johnson and Cortes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Jorge Cortes, Georgia Cancer Center, Augusta University, Augusta, 30912, Georgia, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.